Regeneron Pharmaceuticals REGN
NASDAQ REGN
$827.72 -15.75 (-1.87%)
As of: Sep 4, 2026 · 3:59 PM EDT

Regeneron Pharmaceuticals (REGN) Gross Margin Growth (1y) (2010 - 2026)

Analysis

Regeneron Pharmaceuticals (REGN) Gross Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -91.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 210.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1,966.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 228.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -475.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1,034.00
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 21.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -91.00
Mar 31, 2026 -159.00
Dec 31, 2025 42.00
Sep 30, 2025 -44.00
Jun 30, 2025 -23.00
Mar 31, 2025 -112.00
Dec 31, 2024 -109.00
Sep 30, 2024 -37.00
Jun 30, 2024 -54.00
Mar 31, 2024 23.00
Dec 31, 2023 27,047.00
Sep 30, 2023 -67.00
Jun 30, 2023 -151.00
Mar 31, 2023 -89.00
Dec 31, 2022 -26,161.00
Sep 30, 2022 90.00
Jun 30, 2022 528.00
Mar 31, 2022 25.00
Dec 31, 2021 -923.00
Sep 30, 2021 -68.00